Nutrition in Bronchopulmonary Dysplasia: In the NICU and Beyond

  • Richard A. EhrenkranzEmail author
  • Fernando R. Moya
Part of the Respiratory Medicine book series (RM)


This chapter reviews the role that nutrition plays in the development and management of BPD. While specific nutrients, other than n-3 LCPUFAs and vitamin A, have shown limited benefit in reducing the incidence or severity of BPD, increased intake of mother’s own milk during the NICU hospitalization has been reported to reduce the incidence of BPD. In addition, standardized, evidence-based early nutritional management guidelines for extremely preterm infants that begin with early, intense parenteral and enteral nutritional support have been shown to reduce the growth failure associated with BPD. Hopefully, this strategy will address some of the adverse effects that undernutrition has had on lung growth, injury, and repair, resulting in a decrease in both the incidence and severity of BPD.


Bronchopulmonary dysplasia (BPD) Extremely preterm infant Nutritional support of extremely preterm infant Standardized feeding guidelines Post-discharge nutrition Docosahexaenoic acid (DHA) n-3 LCPUFAs (long-chain polyunsaturated fatty acids) Vitamin A 


  1. 1.
    Ehrenkranz RA, Younes N, Lemons JA, Fanaroff AA, Donovan EF, Wright LL, et al. Longitudinal growth of hospitalized very low birth weight infants. Pediatrics. 1999;104:280–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Clark RH, Thomas P, Peabody J. Extrauterine growth restriction remains a serious problem in prematurely born neonates. Pediatrics. 2003;111:986–90.CrossRefPubMedGoogle Scholar
  3. 3.
    Cole TJ, Statnikov Y, Santhakumaran S, Pan H, Modi N. Postnatal weight gain after very preterm birth. A UK population study. Arch Dis Child. 2011;96 Suppl 1:A1–100.Google Scholar
  4. 4.
    Biniwale MA, Ehrenkranz RA. The role of nutrition in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:200–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Bhatia J, Parish A. Nutrition and the lung. Neonatology. 2009;95:362–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Dani C, Poggi C. Nutrition and bronchopulmonary dysplasia. J Matern Fetal Neonatal Med. 2012;25(S3):37–40.CrossRefPubMedGoogle Scholar
  7. 7.
    Moya F. Preterm nutrition and the lung. In: Koletzko B, Poindexter B, Uauy R, editors. Nutritional care of preterm infants: scientific basis and practical guidelines, World review of nutrition and dietetics, vol. 110. Basel: Karger; 2014. p. 239–52.CrossRefGoogle Scholar
  8. 8.
    Edelman NH, Rucker RB, Peavy HH. NIH workshop summary: nutrition and the respiratory system. Chronic obstructive pulmonary disease (COPD). Am Rev Respir Dis. 1986;134:347–52.PubMedGoogle Scholar
  9. 9.
    Frank L. Nutrition: Influence on lung growth, injury and repair, and development of bronchopulmonary dysplasia. In: Bancalari E, Stocker JT, editors. Bronchopulmonary dysplasia. Washington: Hemisphere Publishing Corporation; 1988. p. 78–108.Google Scholar
  10. 10.
    Frank L, Sosenko IRS. Undernutrition as a major contributing factor in the pathogenesis of bronchopulmonary dysplasia. Am Rev Respir Dis. 1988;138:725–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Ehrenkranz RA. Early, aggressive nutritional management for very low birth weight infants: what is the evidence? Semin Perintaol. 2007;31:48–55.CrossRefGoogle Scholar
  12. 12.
    Wright K, Dawson JP, Fallis D, Vogt E, Lorch V. New postnatal growth grids for very low birth weight infants. Pediatrics. 1993;91:922–6.PubMedGoogle Scholar
  13. 13.
    Radmacher PG, Rafail ST, Adamkin DH. Nutrition and growth in VVLBW infants with and without bronchopulmonary dysplasia. Neonatal Intensive Care. 2004;16:22–6.Google Scholar
  14. 14.
    Theile AR, Radmacher PG, Anschutz TW, Davis DW, Adamkin DH. Nutritional strategies and growth in extremely low birth weight infants with bronchopulmonary dysplasia over the past 10 years. J Perinatol. 2012;32:117–22.CrossRefPubMedGoogle Scholar
  15. 15.
    Ehrenkranz RA, Das A, Wrage LA, Poindexter BB, Higgins R, Stoll BJ, et al. Early nutrition mediates the influence of severity of illness on extremely low birth weight infants. Pediatr Res. 2011;69:522–9.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Poindexter BB, Ehrenkranz RA, Stoll BJ, Wright LL, Poole WK, Oh W, et al. Parenteral glutamine supplementation does not reduce the risk of mortality or late-onset sepsis in extremely low birth weight infants. Pediatrics. 2004;113:1209–15.CrossRefPubMedGoogle Scholar
  17. 17.
    Oh W, Poindexter BB, Perrits R, Lemons JA, Bauer CR, Ehrenkranz RA, et al. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr. 2005;147:786–90.CrossRefPubMedGoogle Scholar
  18. 18.
    McCallie KR, Lee HC, Mayer O, Cohen RS, Hintz SR, Rhine WD. Improved outcomes with a standardized feeding protocol for very low birth weight infants. J Perinatol. 2011;31: S61–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Butler TJ, Szekely LJ, Grow JL. A standardized nutrition approach for very low birth weight neonates improves outcomes, reduces cost and is not associated with increased rates of necrotizing enterocolitis, sepsis or mortality. J Perinatol. 2013;33:851–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Ehrenkranz RA. Ongoing issues in the intensive care for the periviable infant-nutritional management and prevention of bronchopulmonary dysplasia and nosocomial infections. Semin Perinatol. 2014;38:25–30.CrossRefPubMedGoogle Scholar
  21. 21.
    Ehrenkranz RA. Nutrition, growth and clinical outcomes. In: Koletzko B, Poindexter B, Uauy R, editors. Nutritional care of preterm infants: scientific basis and practical guidelines, World review of nutrition and dietetics, vol. 110. Basel: Karger; 2014. p. 11–26.CrossRefGoogle Scholar
  22. 22.
    Torrazza RM, Neu J. Evidence-based guidelines for optimization of nutrition for the very low birthweight infant. NeoReviews. 2013;14:e340–7.CrossRefGoogle Scholar
  23. 23.
    Parker LA, Neu J, Torrazza RM, Li Y. Scientifically based strategies for enteral feeding in premature infants. NeoReviews. 2013;14:e350–8.CrossRefGoogle Scholar
  24. 24.
    Jadcherla SR, Dail J, Malkar MB, McClead R, Kelleher K, Nelin L. Impact of process optimization and quality improvement measures on neonatal feeding outcomes at an all-referral neonatal intensive care unit. JPEN. 2015;Mar 2. pii:014860711571667 (Epub ahead of print).Google Scholar
  25. 25.
    Dutta S, Singh B, Chessell L, Wilson J, Janes M, McDonald K, et al. Guidelines for feeding very low birth weight infants. Nutrients. 2015;7:423–42.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Rønnestad A, Abrahamsen TG, Medbø S, Reigstad H, Lossius K, Kaaresen PI, et al. Late-onset septicemia in a Norwegian national cohort of extremely premature infants receiving very early full human milk feeding. Pediatrics. 2005;115:e269–76.CrossRefPubMedGoogle Scholar
  27. 27.
    Bigger HR, Fogg LJ, Patel AL, Johnson T, Engstrom JL, Meier PP. Quality indicators for human milk use in very low birthweight infants: are we measuring what we should be measuring? J Perinatol. 2013;34:287–91.CrossRefGoogle Scholar
  28. 28.
    Schanler RJ, Lau C, Hurst NM, Smith EO. Randomized trial of donor milk versus preterm formula as substitutes for mothers’ own milk in the feeding of extremely premature infants. Pediatrics. 2005;116:400–6.Google Scholar
  29. 29.
    Sisk PM, Lovelady CA, Dillard RG, Gruber KJ, O’Shea TM. Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol. 2007;27:428–33.Google Scholar
  30. 30.
    Patel AL, Robin B, Buchanan A, Christian E, Nandhan V, Shroff A, et al. Beneficial effect of human milk (HM) on chronic lung disease (CLD) in very low birth weight (VLBW) infants. E-PAS. 2015;1601.754.Google Scholar
  31. 31.
    Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013;13:59.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Olsen IE, Groveman SA, Lawson ML, Clark RH, Zemel BS. New intrauterine growth curves based on United States data. Pediatrics. 2010;125:e214–24.CrossRefPubMedGoogle Scholar
  33. 33.
    Grummer-Strawn LM, Reinold C, Krebs NF. Use of world health organization and CDC growth charts for children aged 0–59 months in the United States. MMWR. 2010; 59(RR-9):1–15.PubMedGoogle Scholar
  34. 34.
    Weinstein MR, Oh W. Oxygen consumption in infants with bronchopulmonary dysplasia. J Pediatr. 1981;99:958–61.CrossRefPubMedGoogle Scholar
  35. 35.
    Kurzner SI, Garg M, Bautista DB, Sargent CW, Bowman CM, Keens TG. Growth failure in bronchopulmonary dysplasia: elevated metabolic rates and pulmonary mechanics. J Pediatr. 1988;112:73–80.CrossRefPubMedGoogle Scholar
  36. 36.
    Kurzner SI, Garg M, Bautista DB, Bader D, Merritt RJ, Warburton D, et al. Growth failure in infants with bronchopulmonary dysplasia: nutrition and elevated resting metabolic expenditure. Pediatrics. 1988;81:379–84.PubMedGoogle Scholar
  37. 37.
    Niermeyer S. Nutrition: nutritional and metabolic problems in infants with bronchopulmonary dysplasia. In: Bancalari E, Stocker JT, editors. Bronchopulmonary dysplasia. Washington: Hemisphere Publishing Corporation; 1988. p. 313–36.Google Scholar
  38. 38.
    Poindexter BB, Ehrenkranz RA. Nutrient requirements and provision of nutritional support in the premature neonate. In: Martin R, Faranoff AA, Walsh M, editors. Neonatal-perinatal medicine. 10th ed. Maryland Heights, MO: Elsevier; 2014. p. 592–612.Google Scholar
  39. 39.
    Oh W. Fluid and electrolyte management of very low birth weight infants. Pediatr Neonatol. 2012;53:329–33.CrossRefPubMedGoogle Scholar
  40. 40.
    VanMarter LJ, Leviton A, Allred EN, Pagano M, Kuban KC. Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants. J Pediatr. 1990;116(6):942–9.CrossRefGoogle Scholar
  41. 41.
    Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants (Review). Cochrane Database Syst Rev. 2010;6:959–80.Google Scholar
  42. 42.
    Hazan J, Chessex P, Piedboeuf B, Bourgeois M, Bard H, Long W. Energy expenditure during synthetic surfactant replacement therapy for neonatal respiratory distress syndrome. J Pediatr. 1992;120(2 Pt 2):S29–33.CrossRefPubMedGoogle Scholar
  43. 43.
    Yunis KA, Oh W. Effects of intravenous glucose loading on oxygen consumption, carbon dioxide production, and resting energy expenditure in infants with bronchopulmonary dysplasia. J Pediatr. 1989;115:127–32.CrossRefPubMedGoogle Scholar
  44. 44.
    Chessex P, Belanger S, Piedboeuf B, Pineault M. Influence of energy substrates on respiratory gas exchange during conventional mechanical ventilation of preterm infants. J Pediatr. 1995;126:619–24.CrossRefPubMedGoogle Scholar
  45. 45.
    De Meer K, Westerterp KR, Houwen RHJ, Brouwers R, Berger R, Okken A. Total energy expenditure in infants with bronchopulmonary dysplasia is associated with respiratory status. Eur J Pediatr. 1997;156:299–304.CrossRefPubMedGoogle Scholar
  46. 46.
    Hallman M, Gluck L. Formation of acidic phospholipids in rabbit lung during perinatal development. Pediatr Res. 1980;14(11):1250–9.CrossRefPubMedGoogle Scholar
  47. 47.
    Hallman M, Saugstad OD, Porreco RP, Epstein BL, Gluck L. Role of myoinositol in regulation of surfactant phospholipids in the newborn. Early Hum Dev. 1985;10(3–4):245–54.CrossRefPubMedGoogle Scholar
  48. 48.
    Howlett A, Ohlsson A, Plakkal N. Inositol for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2012;3:CD000366.Google Scholar
  49. 49.
    Manner T, Wiese S, Katz DP, Skeie B, Askanazi J. Branched-chain amino acids and respiration. Nutrition. 1992;8(5):311–5.PubMedGoogle Scholar
  50. 50.
    Blazer S, Reinersman GT, Askanazi J, Furst P, Katz DP, Fleischman AR. Branched-chain amino acids and respiratory pattern and function in the neonate. J Perinatol. 1994;14:290–5.PubMedGoogle Scholar
  51. 51.
    Porcelli PJ, Sisk PM. Increased parenteral amino acid administration to extremely low-birth weight infants during early postnatal life. J Pediatr Gastroenterol Nutr. 2002;34:174–9.CrossRefGoogle Scholar
  52. 52.
    Wilson DC, Cairns P, Halliday HL, Reid M, McClure G, Dodge JA. Randomised controlled trial of an aggressive nutritional regimen in sick very low birthweight infants. Arch Dis Child. 1997;77:F4–11.CrossRefGoogle Scholar
  53. 53.
    O’Connor DL, Jacobs J, Hall R, Adamkin D, Auestad N, Castillo M, et al. Growth and development of premature infants fed predominantly human milk, predominantly premature infant formula, or a combination of human milk and premature formula. J Pediatr Gastroenterol Nutr. 2003;37(4):437–46.CrossRefPubMedGoogle Scholar
  54. 54.
    Sullivan S, Schanler RJ, Kim JH, Patel AL, Trawöger R, Kiechl-Kohlendorfer U, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. 2010;156(4):562–7.CrossRefPubMedGoogle Scholar
  55. 55.
    Moya F, Sisk PH, Walsh KR, Berseth CL. A new liquid human milk fortifier and linear growth in preterm infants. Pediatrics. 2012;130(4):e928–35.CrossRefPubMedGoogle Scholar
  56. 56.
    Lapillonne A, Groh-Wargo S, Gonzalez C, Uauy R. Lipid needs of preterm infants: updated recommendations. J Pediatr. 2013;162:S37–47.CrossRefPubMedGoogle Scholar
  57. 57.
    Blanco PG, Freedman SD, Lopez MC, Ollero M, Comen E, Laposata M, et al. Oral docosahexaenoic acid given to pregnant mice increases the amount of surfactant in lung and amniotic fluid in preterm fetuses. Am J Obstet Gynecol. 2004;190:1369–74.CrossRefPubMedGoogle Scholar
  58. 58.
    Joss-Moore L, Wang Y, Baack M, Yao L, Norris AW, Yu X, et al. IUGR decreases PPARy and SETD8 Expression in neonatal rat lung and these effects are ameliorated by maternal DHA supplementation. Early Hum Dev. 2010;86:785–91.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Chao AC, Ziadeh BI, Diau GY, Wijendran V, Sarkadi-Nagy E, Hsieh AT, et al. Influence of dietary long-chain PUFA on premature baboon lung FA and dipalmitoyl PC composition. Lipids. 2003;38:425–9.CrossRefPubMedGoogle Scholar
  60. 60.
    Robinson DT, Carlson SE, Murthy K, Frost B, Li S, Caplan M. Docosahexaenoic and arachidonic acid levels in extremely low birth weight infants with prolonged exposure to intravenous lipids. J Pediatr. 2013;162:56–61.CrossRefPubMedGoogle Scholar
  61. 61.
    Martin CR, Dasilva DA, Cluette-Brown JE, Dimonda C, Hamill A, Bhutta AQ, et al. Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities. J Pediatr. 2011;159(5):743–9.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Manley BJ, Makrides M, Collins CT, McPhee AJ, Gibson RA, Ran P, et al. High-dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics. 2011;128:e71–7.CrossRefPubMedGoogle Scholar
  63. 63.
    Zhang P, Lavoie P, Lacaze-Masmonteil T, Rhainds M, Marc I. Omega-3 long-chain polyunsaturated fatty acids for extremely preterm infants: a systematic review. Pediatrics. 2014;134:120–34.CrossRefPubMedGoogle Scholar
  64. 64.
    Sosenko IRS, Rodriguez-Pierce M, Bancalari E. Effect of early initiation of intravenous lipid administration on the incidence and severity of chronic lung disease in premature infants. J Pediatr. 1993;123:975–82.CrossRefPubMedGoogle Scholar
  65. 65.
    Hammerman C, Aramburo MJ. Decreased lipid intake reduces morbidity in sick premature neonates. J Pediatr. 1988;113(6):1083–8.CrossRefPubMedGoogle Scholar
  66. 66.
    Simmer K, Rao SC. Early introduction of lipids to parenterally-fed preterm infants. Cochrane Database Syst Rev. 2005;18(2):CD005256.Google Scholar
  67. 67.
    Gershanik JJ, Levkoff AH, Duncan R. The association of hypocalcemia and recurrent apnea in premature infants. Am J Obstet Gynecol. 1972;113(5):646–52.PubMedGoogle Scholar
  68. 68.
    Altirkawi K, Rozycki H. Hypocalcemia is common in the first 48 h of life in ELBW infants. J Perinat Med. 2008;36:348–53.PubMedGoogle Scholar
  69. 69.
    Pereira-da-Silva L, Costa AB, Pereira L, Filipe AF, Virella D, Leal E, et al. Early high calcium and phosphorus intake by parenteral nutrition prevents short-term bone strength decline in preterm infants. J Pediatr Gastroenterol Nutr. 2011;52(2):203–9.CrossRefPubMedGoogle Scholar
  70. 70.
    Carroll WF, Fabres J, Nagy TR, Frazier M, Roane C, Pohlandt F, et al. Results of extremely-low-birth-weight infants randomized to receive extra enteral calcium supply. J Pediatr Gastroenterol Nutr. 2011;53(3):339–45.CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Hicks P, Rogers S, Hawthorne K, Chen Z, Abrams S. Calcium absorption in very low birth weight infants with and without bronchopulmonary dysplasia. J Pediatr. 2011;158:885–90.CrossRefPubMedGoogle Scholar
  72. 72.
    Bertocci LA, Mize CE, Uauy R. Muscle phosphorus energy state in very-low-birth-weight infants: effect of exercise. Am J Physiol. 1992;262:E289–94.PubMedGoogle Scholar
  73. 73.
    Ichikawa G, Watabe Y, Suzumura H, Sairenchi T, Muto T, Arisaka O. Hypophosphatemia in small for gestational age extremely low birth weight infants receiving parenteral nutrition in the first week after birth. J Pediatr Endocr Met. 2012;25(3–4):317–21.Google Scholar
  74. 74.
    Ross JR, Finch C, Ebeling M, Taylor SN. Refeeding syndrome in very-low-birth-weight intrauterine growth-restricted neonates. J Perinatol. 2013;33:717–20.CrossRefPubMedGoogle Scholar
  75. 75.
    Moltu SJ, Strommen K, Blakstad EW, Almaas AN, Westerberg AC, Brækk E, et al. Enhanced feeding in very-low-birth-weight infants may cause electrolyte disturbances and septicemia – a randomized, controlled trial. Clin Nutr. 2013;32:207–12.CrossRefPubMedGoogle Scholar
  76. 76.
    Caddell J. Evidence for magnesium deficiency in the pathogenesis of bronchopulmonary dysplasia. Magnes Res. 1996;9:205–16.PubMedGoogle Scholar
  77. 77.
    Fridman E, Linder N. Magnesium and bronchopulmonary dysplasia. Harefuah. 2013;152: 158–61.PubMedGoogle Scholar
  78. 78.
    Stigson L, Kjellmer I. Serum levels of magnesium at birth related to complications of immaturity. Acta Paediatr. 1997;86:991–4.CrossRefPubMedGoogle Scholar
  79. 79.
    Katayama Y, Minami H, Enomoto M, Takano T, Hayashi S, Lee Y. Antenatal magnesium sulfate and the postnatal response of the ductus arteriosus to indomethacin in extremely preterm neonates. J Perinatol. 2011;31:21–4.CrossRefPubMedGoogle Scholar
  80. 80.
    Crowther C, Brown J, McKinlay C, Middleton P. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev. 2014;8:CD001060.PubMedGoogle Scholar
  81. 81.
    Spears K, Cheney C, Zerzan J. Low plasma retinol concentrations increase the risk of developing bronchopulmonary dysplasia and long-term respiratory disability in very-low-birth-weight infants. Am J Clin Nutr. 2004;80:1589–94.PubMedGoogle Scholar
  82. 82.
    Beurskens L, Tibboel D, Lindemnas J, Duvekot JJ, Cohen-Overbeek TE, Veenma DC, et al. Retinol status of newborn infants is associated with congenital diaphragmatic hernia. Pediatrics. 2010;126:712–20.CrossRefPubMedGoogle Scholar
  83. 83.
    Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA, et al. Vitamin A supplementation for extremely-low-birth-weight infants. A national institute of child health and human development neonatal research network. N Engl J Med. 1999;340:1962–8.CrossRefPubMedGoogle Scholar
  84. 84.
    Darlow BA, Graham PJ. Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database Syst Rev. 2002;4:CD000501.PubMedGoogle Scholar
  85. 85.
    Londhe V, Nolen T, Das A, Higgins RD, Tyson JE, Oh W, et al. Vitamin A supplementation in extremely low-birth-weight infants: subgroup analysis in small-for-gestational-age infants. Am J Perinatol. 2013;30:771–80.CrossRefPubMedPubMedCentralGoogle Scholar
  86. 86.
    Gadhia M, Cutter G, Abman S, Kinsella J. Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk of bronchopulmonary dysplasia in premature newborns with respiratory failure. J Pediatr. 2014;164:744–8.CrossRefPubMedPubMedCentralGoogle Scholar
  87. 87.
    Ambalavanan N, Tyson JE, Kennedy KA, Hansen NI, Vohr BR, Wtright LL, et al. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics. 2005;115:e249–54.CrossRefPubMedGoogle Scholar
  88. 88.
    Singh A, Bronshtein V, Khashu M, Lee K, Potts JE, Friel J, et al. Vitamin A is systemically bioavailable after intratracheal administration with surfactant in an animal model of newborn respiratory distress. Pedaitr Res. 2010;67:619–23.CrossRefGoogle Scholar
  89. 89.
    Kaplan H, Tabangin M, McClendon D, Meinzen-Derr J, Margolis P, Donovan E. Understanding variation in vitamin A supplementation among NICUs. Pediatrics. 2010;126:e367–73.CrossRefPubMedGoogle Scholar
  90. 90.
    Tolia V, Murthy K, McKinley P, Bennett M, Clark R. The effect of national shortage of vitamin A on death or chronic lung disease in extremely low-birth-weight infants. JAMA Pediatr. 2014;168:1039–44.CrossRefPubMedGoogle Scholar
  91. 91.
    Moreira A, Caskey M, Fonseca R, Malloy M, Geary C. Impact of providing vitamin A to the routine pulmonary care of extremely low birth weight infants. J Matern Fetal Neonatal Med. 2012;25:84–8.CrossRefPubMedGoogle Scholar
  92. 92.
    Peluso A, Hair A, Hawthorne K, Abrams S. Vitamin A and chronic lung disease in infants: what happened when there wasn’t any? Am J Respir Crit Care Med. 2003;168:356–96.Google Scholar
  93. 93.
    Falciglia HS, Johnson JR, Sullivan J, Hall CF, Miller JD, Reichmann GC. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia. Am J Perinatol. 2003;20:97–107.CrossRefPubMedGoogle Scholar
  94. 94.
    Kositamongkol S, Suthutvoravut U, Chongviriyaphan N, Feungpean B, Nuntnarumit P. Vitamin A and E status in very low birth weight infants. J Perinatol. 2011;31:471–6.CrossRefPubMedGoogle Scholar
  95. 95.
    Abdel Ghany E, Alsharany W, Ali A, Younass E, Hussein J. Anti-oxidant profiles and markers of oxidative stress in preterm neonates. Paediatr Int Child Health. 2015, May 4 (Epub ahead of print).Google Scholar
  96. 96.
    Ehrenkranz RA, Bonta BW, Ablow RC, Warshaw JB. Amelioration of bronchopulmonary dysplasia after vitamin E administration. A preliminary report. N Engl J Med. 1978;299: 564–9.CrossRefPubMedGoogle Scholar
  97. 97.
    Ehrenkranz RA, Ablow RC, Warshaw JB. Effect of vitamin E on the development of oxygen-induced lung injury in neonates. Ann N Y Acad Sci. 1982;393:452–66.CrossRefPubMedGoogle Scholar
  98. 98.
    Brion LP, Bell EF, Raghuveer TS. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2003;4:CD003665.PubMedGoogle Scholar
  99. 99.
    Darlow B, Inder T, Graham P, Sluis KB, Malpas TJ, Taylor BJ, et al. The relationship of selenium status to respiratory outcome in the very low birth weight infant. Pediatrics. 1995;96:314–9.PubMedGoogle Scholar
  100. 100.
    Mostafa-Gharehbaghi M, Mostafa-Gharahbaghi P, Ghanbari F, Abdolmohammad-Zadeh H, Sadeghi GH, Jouyban A. Determination of selenium in serum samples of preterm newborn infants with bronchopulmonary dysplasia using a validated hydride generation system. Biol Trace Elem Res. 2012;147:1–7.CrossRefPubMedGoogle Scholar
  101. 101.
    Darlow B, Winterbourn C, Inder T, Graham PJ, Harding JE, Weston PJ, et al. The effect of selenium supplementation on outcome in very low birth weight infants: a randomized controlled trial. The New Zealand neonatal study group. J Pediatr. 2000;136:473–80.CrossRefPubMedGoogle Scholar
  102. 102.
    American Academy of Pediatrics Committee on Fetus and Newborn. Hospital discharge of the high-risk neonate. Pediatrics. 2008;122:1119–26.CrossRefGoogle Scholar
  103. 103.
    Ballard RA. Pediatric care of the ICN Graduate. Philadelphia: WB Saunders; 1988.Google Scholar
  104. 104.
    Brodsky D, Oullette MA. Primary care of the premature infant. Philadelphia: Saunders/Elsevier; 2008.Google Scholar
  105. 105.
    Nzegwu NI, Ehrenkranz RA. Post-discharge nutrition and the VLBW infant: to supplement or not supplement? A review of the current evidence. Clin Perinatol. 2014;41:463–74.CrossRefPubMedGoogle Scholar
  106. 106.
    Allen J, Zwerdling, Ehrenkranz R, Gaultier C, Geggel R, Greenough A, et al. Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med. 2003;168:356–96.Google Scholar
  107. 107.
    Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–9.CrossRefPubMedGoogle Scholar
  108. 108.
    Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AC, Wright LL, Fanaroff AA, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics. 2005;116:1353–60.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of Pediatrics/Section of Neonatal-Perinatal MedicineYale University School of MedicineNew HavenUSA
  2. 2.Betty Cameron Children’s HospitalWilmingtonUSA

Personalised recommendations